Palomino Laboratories (PALX) Change in Account Payables (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of Change in Account Payables data on file, last reported at $51161.0 in Q3 2025.

• For the quarter ending Q3 2025, Change in Account Payables rose 699.43% year-over-year to $51161.0; the trailing twelve-month figure through Sep 2025 stood at $25696.0 (up 509.63% YoY), and the FY2024 full-year result was -$32000.0, down 288.24% from the prior year.
• Change in Account Payables grew to $51161.0 in Q3 2025, from $1114.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $51161.0 in Q3 2025 to a low of -$31965.0 in Q4 2024.
• A 3-year average of $3795.7 and a median of $4250.0 in 2023 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables sank 852.12% in 2024 and soared 699.43% in 2025, its largest moves.
• Tracing PALX's Change in Account Payables over 3 years: stood at $4250.0 in 2023, then slumped by 852.12% to -$31965.0 in 2024, then soared by 260.05% to $51161.0 in 2025.
• Business Quant data shows PALX's Change in Account Payables at $51161.0 in Q3 2025, $1114.0 in Q2 2025, and $5386.0 in Q1 2025.